Correlation Between Axim Biotechnologies and Kane Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axim Biotechnologies and Kane Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axim Biotechnologies and Kane Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axim Biotechnologies and Kane Biotech, you can compare the effects of market volatilities on Axim Biotechnologies and Kane Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axim Biotechnologies with a short position of Kane Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axim Biotechnologies and Kane Biotech.

Diversification Opportunities for Axim Biotechnologies and Kane Biotech

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Axim and Kane is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Axim Biotechnologies and Kane Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kane Biotech and Axim Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axim Biotechnologies are associated (or correlated) with Kane Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kane Biotech has no effect on the direction of Axim Biotechnologies i.e., Axim Biotechnologies and Kane Biotech go up and down completely randomly.

Pair Corralation between Axim Biotechnologies and Kane Biotech

Given the investment horizon of 90 days Axim Biotechnologies is expected to generate 1.75 times less return on investment than Kane Biotech. In addition to that, Axim Biotechnologies is 2.67 times more volatile than Kane Biotech. It trades about 0.02 of its total potential returns per unit of risk. Kane Biotech is currently generating about 0.08 per unit of volatility. If you would invest  4.20  in Kane Biotech on September 1, 2024 and sell it today you would earn a total of  4.48  from holding Kane Biotech or generate 106.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Axim Biotechnologies  vs.  Kane Biotech

 Performance 
       Timeline  
Axim Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Axim Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak forward indicators, Axim Biotechnologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Kane Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kane Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Axim Biotechnologies and Kane Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axim Biotechnologies and Kane Biotech

The main advantage of trading using opposite Axim Biotechnologies and Kane Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axim Biotechnologies position performs unexpectedly, Kane Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kane Biotech will offset losses from the drop in Kane Biotech's long position.
The idea behind Axim Biotechnologies and Kane Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio